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Background. The prolonged survival of patients with cystic fibrosis leads to the search for predictors that determine their 
physical health and functioning in social and psycho-emotional areas, and allows for better understanding of the mutual interactions.
Objectives. The aim of the study was to assess the incidence of pain in patients with CF and clinical determinants of anxiety, depression 
and aggression.
Material and methods. The study covered 95 patients with CF aged 14–25 years. The analysis included: the intensity of pain (numeric 
rating scale), the level of anxiety, depression and aggression (hospital anxiety and depression scale), the quality of sleep (athens 
insomnia scale), FeV1 and Bmi.
Results. 42.1% (n = 40) of patients with CF experienced pain, mainly moderate (n = 18; 45%) and severe (n = 14; 35%). in these patients, 
significantly higher median anxiety scores (6 vs 4) and median depression scores (3.5 vs 2) were recorded than in subjects without pain. 
Factors considerably determining anxiety scores were ais scores (ß = 0.56) and sex (ß = 0.22), while depression scores were determined 
by ais scores (ß = 0.56), Bmi (ß = -0.20) and pain intensity (ß = 0.20). in turn, sex (ß = 0.30) and ais scores (ß = 0.19) had an influence 
on aggression scores.
Conclusions. pain occurs in a large proportion of patients with CF. Factors determining emotional disorders in patients with CF are 
pain, female sex, quality of sleep and body weight. anxiety, depression and aggression have always been accompanied by poorer sleep 
quality.
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Background
despite the fact that the development of medicine allows 
for better understanding and opens new pathways for the treat-
ment of cystic fibrosis (CF), the condition continues to be a life-
-threatening disorder [1].
The prolonged survival of patients with CF leads to the search 
for predictors that determine their physical health and function-
ing in social and psycho-emotional areas, and allow for better 
understanding of the mutual interactions. The biological state of 
a patient with CF is already well understood and described [2], 
but the links between the biological state and other factors, for 
instance emotional, require further deepening of research.
identified factors destabilizing the condition of a patient 
with CF include pain [3], sleep disorders [4] and negative emo-
tions [5]. pain is considered to be common in patients with CF, 
but its connotation and importance for the patient’s function-
ing still appear to be underestimated. The pain problem in CF is 
sometimes ignored, and assumed to be an unspecific symptom. 
Clinical practice suggests that pain in this group of patients may 
accompany osteoporosis, spinal curvature, arthritis, sinusitis, 
emphysema and complications in the alimentary tract [6]. also, 
physiotherapy may cause muscle tension that induces chest 
and back pain, and conversely, intense dyspnea and cough may 
cause painful contractions of intercorsal muscles [7]. pain is 
a common problem in both children and adults with CF. it has 
negative clinical associations with life quality and the ability to 
successfully undertake treatment [3, 8].
pain is also associated with depression, and depression may 
be a risk factor for the development of pain in patients with CF 
[9]. negative emotions predispose patients towards higher per-
ception of pain on one hand, but on the other hand, continuous 
pain, in its effects, may influence the incidence of negative emo-
tions. although epidemiological studies continue to provide 
data and information that could lead to a better understanding 
of the clinical manifestations of the disease, there are still many 
controversies regarding the importance of some risk factors, 
such as pain and depression in the pathogenesis of this disorder, 
and its management [10]. The findings emphasis the need to 
screen patients with CF for symptoms of depression and to treat 
co-morbid depression. There is an important need to continue 
to promote an integrated team approach to CF care, and to un-
derline the need for multidisciplinary CF care teams to include 
a clinical psychologist.
pain can lead to sleep disorders, which depend on the sever-
ity of the disease, the patient's sensitivity, previous treatments, 
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and the efficacy of analgesics. The combination of symptoms 
caused by the disorder and sleep problems produce deeper 
physical and mental discomfort, leading to disorganization of 
social and individual functioning [11]. assessing the mutual 
interactions between anxiety, depression and aggression, with 
particular emphasis on pain and quality of sleep, is necessary, 
especially in adolescents and young adults with CF. young 
people may not have fully developed skills of coping with the 
disease and therapy, and developmental tasks may make them 
particularly susceptible to emotional stress. anxiety seems to 
be the basic background for emotional life, against which anger, 
annoyance, depression, lack of self-confidence, helplessness 
and the loss of control over the body appear. 
Objectives
The aim of the study was to assess the incidence of pain in 
patients with CF, and to examine the demographic and clinical 
determinants of anxiety, depression and aggression. 
Materials and methods 
Setting
The study comprised 95 subjects with CF, both sexes, aged 
14–25 years, who reported to the follow up visit at the institute 
of Tuberculosis and Lung diseases in rabka zdroj.
The research was carried out between February 10, 2016 
and February 28, 2017, and was approved by the Bioeth-
ics Commission of the Jagiellonian university in krakow (no. 
122.6120.275.2015).
Participans
The inclusion criterion was stable state of health in the 4 
weeks prior to enrolment (no worsening of clinical status, e.g. 
aggravation of dyspnea or cough, coughing up sputum, the use 
of assisted breathing or respirotherapy). The study excluded pa-
tients who did not consent to participate in the study (the legal 
guardian’s consent was necessary for patients under the age of 
18), those after lung transplantation, or with mental or terminal 
diseases, and people who had traumatic experiences in the last 
6 months (e.g. relationship breakdown, death of a significant 
person, job loss). 
The level of pain intensity and pain relief were assessed us-
ing the numeric rating scale, where 0 meant no pain/no pain 
relief, and 10 maximum pain/complete pain relief. The results of 
pain assessment were interpreted as: weak (1–3/10), moderate 
(4–6/10), and strong (over 6/10). 
The hospital anxiety and depression scale (hads), which 
was modified to assess the level of aggression and validated to 
polish conditions, was used to evaluate anxiety and depression. 
in depression and anxiety subscales, the patient can obtain from 
0 to 21 points (normal: 0–7 points, borderline: 8–10 points, clin-
ical levels of symptoms ≥ 11 points); in the aggression subscale 
from 0 to 6 points (the higher the number of points, the higher 
the level of aggression). 
The polish version of the athens insomnia scale (ais) was 
used to assess the quality of sleep. if the symptom occurred at 
least three times a week during the last month, the patient as-
sessed its severity on a scale of 1–3 points (0 was no symptom). 
a total score of at least 8/24 points may indicate insomnia. 
a metric of our own design has been used to collect so-
ciodemographic data and basic information about the patient’s 
general state of health. information on FeV1 values over the last 
4 weeks was obtained from patients’ medical records. 
Statistical methods
statistical analysis was performed using statistica 12 
software, including the "medical Bundle" (statsoft®, poland). 
intergroup differences for quantitative variables were verified 
using the t-student or mann–whitney test based on the 
distribution of variables, while chi2 and Fisher’s exact test were 
used for qualitative variables. Correlations between values of 
numerical parameters were determined on the basis of spear-
man’s (R) rank correlation coefficient. 
a linear stepwise reverse regression was used to investigate 
demographic and clinical factors affecting anxiety, depression and 
aggression. The sum of points obtained in anxiety, depression and 
aggression subscales was a dependent variable. The logistic re-
gression model was used to calculate the odds ratio for anxiety 
and depressive disorders depending on gender and the presence 
of insomnia. statistical significance was assumed at p = 0.05. 
Results 
Participants and descriptive date 
statistical analysis was based on the results from 95 ques-
tionnaires that were completed mostly by male patients 
(56.8%), aged 17–25 years (73.7%). patients who declared ex-
periencing pain were assigned to the pain group (42.1%), while 
those who did not feel pain were assigned to the no pain group 
(57.9%). demographic and clinical characteristics of patients are 
presented in Table 1.
Table 1. Comparison of patients in terms of demographic and 
clinical characteristics based on reporting of pain
Parameter Pain
(n = 40)
No pain
(n = 55)
p
age (years) 14–16 9 (22.5%) 16 (29.1%) χ2 = 0.577;  
p = 0.74917–20 15 (37.5%) 20 (36.4%)
21–25 16 (40.0%) 19 (34.5%)
sex Girls 20 (50.0%) 21 (38.2%) χ2 = 1.318;  
p = 0.250Boys 20 (50.0%) 34 (61.8%)
Bmi (kg/m2) 19.6 ± 2.5 20.1 ± 3.1 t = -0.706;  
p = 0.481
FeV1 (% of pred.) 68.6 ± 25.4 67.9 ± 20.7 t = -0.144;  
p = 0.885
anxiety (scores) 6 (4–10) 4 (2–8) Z = -1.994;  
p = 0.046
depression (scores) 3.5 (2–7.5) 2 (1–6) Z = -2.199;  
p = 0.027
aggression (scores) 3.5 (2–4) 3 (2–4) Z = -0.893;  
p = 0.371
ais (scores) 6.5 (4–10) 5 (3–8) Z = -1.239;  
p = 0.214
Co-morbidi-
ties*
yes 16 (40.0%) 29 (52.7%) χ2 = 1.504;  
p = 0.219no 24 (60.0%) 26 (47.3%)
results presented as medians (interquartile ranges), mean (standard 
deviation) or numbers (percentages). abbreviations: Bmi – body mass 
index; FeV1 – forced expiratory volume in 1 s; ais – athens insomnia 
scale, * the co-morbidities included diabetes (n = 16), bronchial asthma 
(n = 15), nasal polyps (n = 10) and cholelithiasis (n = 8). 
Main results
Prevalence of pain 
in the pain group 8 patients (20%) suffered from mild, 18 
from moderate (45%) and 14 from strong pain (35%). 
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Table 3. Predictors of depression, the results of linear stepwise 
reverse regression (n = 95)
Predictors ß SE 
of ß
b SE 
of b
t p
ais scores 0.56 0.08 0.42 0.061 6.933 0.000
Bmi -0.20 0.07 -0.27 0.104 -2.619 0.010
pain intensity 0.20 0.08 0.23 0.097 2.435 0.016
ß – standardized regression coefficient; b – non-standardized regres-
sion coefficient; se – standard error; R2 – determination coefficient; 
ais – athens insomnia scale; R2 = 0.43; F(3.91) = 22.560; p = 0.000. 
Aggression
aggression scores were determined by sex and ais scores. 
Gender and ais scores explained 15% of aggression variable 
variances (Table 4). The level of aggression moderately corre-
lated with the level of anxiety (R = 0.41; t = 4.401; p = 0.000). sig-
nificantly higher levels of aggression were recorded in women 
than in men (me: 4 vs 2.5; Z = 3.249; p = 0.000). The odds of 
a higher level of aggression in female patients with CF are 1.6 
times greater than in male patients (or: 1.6; 95% Ci: 1.19 to 
2.14). 
Table 4. Predictors of aggression, the results of linear stepwise 
reverse regression (n = 95)
Predictors ß SE of ß b SE of b t p
sexwomen 0.30 0.09 0.47 0.15 3.066 0.002
ais scores 0.19 0.09 0.06 0.03 1.994 0.049
ß – standardized regression coefficient; b – non-standardized regression 
coefficient; se – standard error; R2 – determination coefficient; ais – ath-
ens insomnia scale; R2 = 0.15; F(2.92) = 8.254; p = 0.000. 
Discussion
Key results
our study revealed that a significant proportion of CF ado-
lescents and young adults experienced pain, as in the study con-
ducted by Festini et al. [6]. nearly 90% of the subjects indicated 
one source of pain, among which the digestive tract, head and 
respiratory system dominated. Lechnitz et al. [8] and hayes et 
al. [12] obtained similar results in terms of pain location, where-
as in the study conducted by moraru et al. [10] nearly 34% of 
patients complained of various pain manifestations. 
The study demonstrated a positive correlation between the 
level of pain intensity and the number of its source, but the cor-
relation was moderate. analgesia used by patients was primar-
ily based on the immediate oral administration of paracetamol, 
metamizol and non-steroidal anti-inflammatory drugs. in the 
subjects’ opinion, analgesic treatment brought considerable 
pain relief. The results could have been influenced by the stable 
state of the patient’s health, but the effectiveness of analgesia 
could also result from good education about pain management 
by the medical team, especially nurses. Given the amount of 
time devoted to patients, nursing teams can use their profes-
sional competence to provide patients with information sup-
port for pharmacological and non-pharmacological methods of 
fighting pain and reducing anxiety [13]. 
The analysis of the material has confirmed the relationship 
between pain and higher levels of anxiety and depression. simi-
lar results were obtained by hayes et al. [12], proving that symp-
toms of depression and anxiety were more common among pa-
tients with pain. importantly, the authors have demonstrated 
the association of pain not only with the greater risk of negative 
emotional states, but also with the higher probability of death. 
The relationship between pain and aggression was not 
shown in our study. higher levels of aggression have been re-
The most common was pain of the abdomen (50%), head 
(47.5%) and chest (37.5%). Less frequently, pain was felt in the 
muscles (12.5%), spine (5%) and joints (5%). one source of 
pain was found in 35 (87.5%) patients, while in the remaining 
subjects it was located in several areas of the body. There was 
a moderate correlation between pain intensity and the number 
of pain sources (R = 0.44; t = 3.081; p = 0.003). 
analgesic treatment was mainly based on the immediate 
administration of non-steroidal anti-inflammatory drugs and/ 
/or paracetamol and/or metamizol (70%). patients took medica-
tions mainly after physical activity, when the pain intensity was 
≥ 3/10 (mean pain relief after analgesic treatment was 7.7 ± 1.8). 
The evaluation of the relationship between pain, 
emotional disorders and the quality of sleep 
patients with pain had significantly higher median anxiety 
scores and median depression scores than those without pain 
(Table 1). pain intensity poorly correlates with anxiety scores 
(R = 0.25; t = 2.498; p = 0.014) and depression scores (R = 0.27; 
t = 2.277; p = 0.006). 
There was no significant difference between patients from 
the pain and no pain groups in terms of aggression scores and 
ais scores (Table 1). 
The evaluation of emotional disorder 
determinants 
Anxiety
in the whole study group, anxiety disorders were diagnosed 
in 16 subjects (16.8%) and “borderline cases” in 17 (17.9%) pa-
tients with CF. 
Factors determining anxiety scores were ais scores and sex. 
This model explained 41% of anxiety scores variable variances 
(Table 2, model 1). if an insomnia variable was introduced into the 
regression model instead of ais scores, then the model explained 
31% of anxiety scores variable variances (Table 2, model 2).
Table 2. Predictors of anxiety, the results of linear stepwise 
reverse regression (n = 95)
Predictors ß SE 
of ß
b SE 
of b
t p
Model 1. R2 = 0.41; F(2.92) = 33.040; p = 0.00
ais scores 0.56 0.08 0.49 0.07 6.935 0.000
sexwomen 0.22 0.08 0.95 0.34 2.758 0.007
Model 2. R2 = 0.31; F(2.92) = 21.635; p = 0.00
insomnia 0.45 0.08 1.99 0.37 5.280 0.000
sexwomen 0.26 0.08 1.13 0.36 3.075 0.002
ß – standardized regression coefficient; b – non-standardized regression 
coefficient; se – standard error; R2 – determination coefficient; ais – ath-
ens insomnia scale.
median anxiety scores were significantly higher in patients 
with insomnia than in those with good quality of sleep (10 vs 
4; Z = -4.549; p = 0.000), and in women than in men (7 vs 4, 
 Z = 3.354; p = 0.000). The odds of anxiety disorders are 5.2 times 
higher in female patients with CF than in male patients (or: 
5.17; 95% Ci: 1.52 to 17.53). 
Depression 
depression was diagnosed in 6 patients (6.3%), and there 
were 12 “borderline cases” (12.6%) among subjects with CF. 
depression scores strongly correlated with anxiety scores 
(R = 0.72; t = 10.005; p = 0.000). Factors determining depres-
sion scores were: ais scores, Bmi and pain intensity. These 
variables explained 43% of depression scores variable vari-
ances (Table 3).
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and institutions providing medical care. mutual connotations 
between the study variables hinder the clinical assessment of 
the patient’s condition and generate considerable costs for the 
treatment of these patients. at the same time, making a diag-
nosis of some negative emotional states can be difficult because 
of the wide range of symptoms, especially in young people [23]. 
understanding the interactions between these variables is very 
important in the treatment process [24, 25] (both for nurses, 
physicians and patients).
Why are the study results important?
The research tools are easy to use and can be applied by 
nursing teams and physicians. They serve for the examination 
of both young and adult patients, enabling us to objectify the 
results in different age groups. The examination of patients with 
risk factors, such as female gender, sleep disorders and pain is 
particularly indicated.
The implications for clinical practice
The popularization of the need for screening in the study 
area can improve the well-being of patients and reduce the cost 
of treatment.
Limitations of the study
The evaluation of anxiety and depression using only 
a screening tool, sleep assessment without objective tests (e.g. 
polysomnography), no control group, the lack of information on 
how often the subjects reported pain during the day, and the 
distinction between acute and chronic pain.
Conclusions
Factors determining emotional disorders in patients with CF 
include female gender, the quality of sleep, pain intensity and 
Bmi. anxiety, depression and aggression are always accompa-
nied by poor quality of sleep. The greater the pain intensity and 
the lower the Bmi, the higher the severity of depressive symp-
toms in patients with CF. 
ported in female patients and those with sleep disorders. higher 
levels of aggression also correlated with greater anxiety. it is dif-
ficult to compare the results because it was not possible to find 
studies based on the hads scale extended by the part diagnos-
ing aggression. 
The problem of anxiety and depression is of particular im-
portance among patients with CF due to the connotation with 
the patient’s biological state. Being subjective experiences, anx-
iety and depression coexist with neurophysiological changes, 
and thus they can also somatise [14]. The studied emotions are 
also capable of mutual interactions, and by worsening the con-
dition of a patient with CF they become determinants of his/ 
/her survival time [15, 16]. duff et al. [17] demonstrated that 
feeling unwell was associated with increased depression scores, 
whereas dantzer et al. [18] highlights the association between 
pathophysiological processes, such as inflammation, and in-
creased depressive symptoms identified in the context of other 
medical conditions. The relationship between depression and 
anxiety was confirmed in our study results. The severity of anxi-
ety and depressive symptoms was dependent on the quality of 
sleep. matsuda and Tully [19] reported a relationship between 
poor quality of sleep and increased risk of depression and anxi-
ety. in turn, Backström-eriksson et al. [20] noted that females 
are more likely to suffer from anxiety disorders, as confirmed 
by our results. 
apart from the quality of sleep and anxiety, the level of de-
pression was also affected by low Bmi and pain intensity. There 
have been no reports on the association between Bmi and de-
pression in patients with CF. The literature mainly contains re-
ports on the relationship between depression and overweight/ 
/obesity or anorexia [21, 22]. in patients with cystic fibrosis, 
Bmi is a measure of physical well-being and good health con-
trol. Thus, a decrease in Bmi can be perceived by the patient as 
a sign of deterioration of the health condition and, consequent-
ly, a shortening of survival time, becoming a factor destabilizing 
the psycho-emotional state.
The results of our study clearly indicate the relationship 
between pain, weight and sleep disorders, including insom-
nia, and the development of negative emotional states. This 
is of importance both for the patient and therapeutic teams 
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